The severe AMD group had a significantly higher RBP4 level than the healthy/mild AMD group (36.78 ± 8.3 and 30.43 ± 7.0 μg/mL, respectively; p < 0.0001) (Figure 1). Here, RBP4 is linked to age-related macular degeneration.